Plain-English translation of NCT07794527 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a combination of three targeted numbing injections—called nerve blocks—can help people recover better after off-pump coronary artery bypass surgery. Instead of relying heavily on opioid pain medications (which can cause serious side effects like breathing problems and confusion), these injections numb specific areas of the chest and leg where surgery causes pain. The goal is to help you wake up faster, move around sooner, and feel more alert after your operation.
After heart bypass surgery, strong opioid pain medications are commonly used, but they can slow your breathing, cause confusion, and delay your recovery. This treatment offers a safer way to control pain without as many of these risks, potentially helping you heal faster and go home sooner.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive standard anesthesia for your surgery. Before the operation begins, you will randomly receive either the three targeted numbing injections in your chest and leg, or placebo injections (saline that does nothing). You and your surgical team will not know which group you are in. After surgery, your pain will be carefully monitored, and your recovery progress—including how quickly you can breathe on your own, move around, and leave the hospital—will be tracked and compared between the two groups.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
Egypt